Diagnostic et traitement des varices des membres inférieurs - KCE
Diagnostic et traitement des varices des membres inférieurs - KCE
Diagnostic et traitement des varices des membres inférieurs - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
12 Varicose Veins <strong>KCE</strong> Reports 164<br />
2.2 ASSESSING METHODOLOGICAL QUALITY AND RISK OF<br />
BIAS<br />
2.2.1 <strong>Diagnostic</strong> studies<br />
The m<strong>et</strong>hodological quality of diagnostic studies was assessed using the QUADAS tool 38<br />
by a team of three reviewers (FA, MK, SM). The papers were divided amongst the three<br />
reviewers and then swapped over for double quality assessment. Any uncertainties<br />
were discussed b<strong>et</strong>ween the three reviewers. The QUADAS tool is structured as a list<br />
of 14 questions addressing aspects of the study <strong>des</strong>ign such as patient population, the<br />
reference and index tests and wh<strong>et</strong>her there is blinding of the tests (see appendix<br />
9.2.1). These questions are scored “yes”, “no” or “unclear” and an assessment of the<br />
m<strong>et</strong>hodological quality of each study involved investigation of the individual quality items<br />
rather than using a combined quality score 38 . The results are in appendix 9.2.2.<br />
2.2.2 Systematic reviews<br />
The m<strong>et</strong>hodological quality of systematic reviews and associated risk of bias were rated<br />
using the SIGN tool a . This tool uses a scale of ratings ranging from (well covered,<br />
adequately addressed, not addressed, not reported and not applicable).The assessment<br />
of the risk of bias in the included SRs was conducted by a team of three reviewers<br />
(FA,MK,SM) who pre-agreed the ratings before beginning quality analysis. In order for<br />
systematic reviews to be included, three of the four following criteria had to be rated as<br />
“well covered” or “adequately addressed”:<br />
• Appropriate and clearly focussed study question;<br />
• Description of m<strong>et</strong>hodology; sufficiently rigorous literature searches (defined<br />
according to SIGN SR quality appraisal tool e.g. Medline, EMBASE, Cochrane<br />
and hand searching of reference lists);<br />
• Quality and m<strong>et</strong>hodological strengths and weaknesses of identified data<br />
assessed and taken into account.<br />
The results of the quality appraisal of systematic reviews are in Appendix 9.3.<br />
2.2.3 Randomised controlled trials<br />
The m<strong>et</strong>hodological quality of selected RCTs was rated using a modified version of the<br />
SIGN tool. The assessment of the risk of bias in the included RCTs was conducted by a<br />
team of three reviewers (FA, MK, SM). In order for RCTs to be included, two of the<br />
four following criteria had to be rated as “well covered” or “adequately addressed”:<br />
• Randomisation;<br />
• Blinding of outcome assessment;<br />
• Treatment groups comparable at baseline;<br />
• Description of dropouts and withdrawals.<br />
The quality appraisal tool and the results are in Appendix 9.5.<br />
2.3 DATA EXTRACTION<br />
2.3.1 <strong>Diagnostic</strong> studies<br />
The DET for diagnostic studies captured the following information: reference, country,<br />
patient numbers and characteristics, index test, reference test, diagnostic accuracy<br />
outcomes e.g. sensitivity, specificity, clinical significant outcomes e.g. decision to<br />
perform surgery, results and <strong>des</strong>cription of quality appraisal (see appendix 9.2.3).<br />
Data extraction of the papers was performed by a reviewer (FA) into a pre-prepared<br />
Word ® table. Extraction was verified in full by a second reviewer (MK). Any<br />
discrepancies were resolved through discussion with the third reviewer (SM).<br />
a http://www.sign.ac/m<strong>et</strong>hodology/checklists.html